Anlon Healthcare Limited (AHCL) — NSE Stock Analysis

Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Share price: ₹15.87.

Company Overview

Anlon Healthcare Limited is a research-driven manufacturer specializing in high-purity pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Established in 2013 and headquartered in Rajkot, the company has rapidly gained recognition for adhering to rigorous international quality standards, supplying products that meet the regulatory requirements of major health authorities such as the FDA, WHO-GMP, and cGMP. Anlon Healthcare’s portfolio comprises a diverse range of APIs, nutraceutical ingredients, and intermediates utilized across pharmaceutical, personal care, and veterinary sectors. The company is notable for both standard product lines and custom manufacturing solutions, servicing customers in India and select international markets. Its R&D-focused approach has enabled the development of challenging and specialized molecules, including unique compounds like Loxoprofen Sodium Dihydrate for pain management. By expanding its manufacturing capacity significantly, Anlon Healthcare positions itself as a vital player in the evolving pharmaceutical supply chain, supporting both formulation companies and end-users with advanced quality control and regulatory compliance.

Valuation Snapshot

• Market cap: —
• P/E: —
• P/B: —
• ROE: —

Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.